Ningjing Lei

917 total citations
38 papers, 691 citations indexed

About

Ningjing Lei is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Ningjing Lei has authored 38 papers receiving a total of 691 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 13 papers in Cancer Research and 11 papers in Oncology. Recurrent topics in Ningjing Lei's work include Lymphatic System and Diseases (5 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Immunotherapy and Immune Responses (4 papers). Ningjing Lei is often cited by papers focused on Lymphatic System and Diseases (5 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Immunotherapy and Immune Responses (4 papers). Ningjing Lei collaborates with scholars based in China, United States and Australia. Ningjing Lei's co-authors include Ruixia Guo, Liping Dai, Lei Chang, Junying Zhou, Mengyu Chen, Yong Li, Bo Peng, Jian-Ying Zhang, Ping Chen and Pei Li and has published in prestigious journals such as Advanced Functional Materials, Cancer Research and Scientific Reports.

In The Last Decade

Ningjing Lei

35 papers receiving 686 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ningjing Lei China	16	453	272	111	111	78	38	691
Bin Kang China	16	551 1.2×	280 1.0×	182 1.6×	106 1.0×	89 1.1×	39	842
Changhao Liu China	15	366 0.8×	204 0.8×	110 1.0×	55 0.5×	68 0.9×	46	682
Duo Wen China	18	513 1.1×	361 1.3×	106 1.0×	60 0.5×	75 1.0×	36	848
Xifa Zhou China	16	583 1.3×	354 1.3×	190 1.7×	81 0.7×	104 1.3×	34	817
Jiazhang Wei China	14	324 0.7×	194 0.7×	126 1.1×	94 0.8×	75 1.0×	46	606
Caroline Contat Switzerland	5	381 0.8×	274 1.0×	169 1.5×	222 2.0×	80 1.0×	5	715
Pierre‐Benoit Ancey France	10	555 1.2×	385 1.4×	185 1.7×	228 2.1×	84 1.1×	10	927
Xuli Meng China	14	489 1.1×	220 0.8×	257 2.3×	128 1.2×	114 1.5×	43	792
Haozhe Piao China	18	435 1.0×	221 0.8×	179 1.6×	100 0.9×	101 1.3×	54	791

Countries citing papers authored by Ningjing Lei

Since Specialization

Citations

This map shows the geographic impact of Ningjing Lei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ningjing Lei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ningjing Lei more than expected).

Fields of papers citing papers by Ningjing Lei

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ningjing Lei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ningjing Lei. The network helps show where Ningjing Lei may publish in the future.

Co-authorship network of co-authors of Ningjing Lei

This figure shows the co-authorship network connecting the top 25 collaborators of Ningjing Lei. A scholar is included among the top collaborators of Ningjing Lei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ningjing Lei. Ningjing Lei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Fazhan, Xiaohan Lou, Fang Wu, et al.. (2025). A Spleen‐Targeted Tolerogenic mRNA‐LNPs Vaccine for the Treatment of Experimental Asthma. Advanced Science. 12(13). e2412543–e2412543. 9 indexed citations

Ren, Yueping, Fang Wu, Jing Xiao, et al.. (2025). Tolerogenic nanovaccines for the treatment of type I allergic diseases. Journal of Controlled Release. 380. 664–685.

Li, Tianyuan, et al.. (2025). Metabolomics- and Proteomics-Based Disease Diagnostic Classifier Model for the Prediction and Diagnosis of Colorectal Carcinoma. Journal of Proteome Research. 24(4). 2096–2111.

Zhang, Meng, Shouying Du, Xiaohan Yao, et al.. (2025). Engineering a spleen-selective mRNA-LNPs vaccine by decoupling the inflammation from cellular immunity-mediated cancer immunotherapy. Theranostics. 15(18). 9643–9662.

Zhu, Linyu, et al.. (2024). IFN-γ-responsiveness of lymphatic endothelial cells inhibits melanoma lymphatic dissemination via AMPK-mediated metabolic control. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1870(7). 167314–167314. 1 indexed citations

Li, Yongjuan, Yayun Wang, Xiaohan Lou, et al.. (2024). A polymeric nanoplatform enhances the cGAS-STING pathway in macrophages to potentiate phagocytosis for cancer immunotherapy. Journal of Controlled Release. 373. 447–462. 14 indexed citations

Wu, Fang, et al.. (2024). Microenvironment-responsive nanosystems for ischemic stroke therapy. Theranostics. 14(14). 5571–5595. 18 indexed citations

Zeng, Qian, et al.. (2024). Construction of a nomogram for personalized prediction of lower limb lymphedema risk after cervical cancer surgery. BMC Women s Health. 24(1). 593–593. 1 indexed citations

Li, Yongjuan, Xinyan Li, Mengzhe Zhang, et al.. (2024). Spatiotemporal orchestration of a ferroptosis-immunotherapy “cycle” via a sequential drug delivery system for antitumor immunity. Nano Today. 59. 102535–102535. 3 indexed citations

10.

Li, Yongjuan, Ningjing Lei, Xiaohan Yao, et al.. (2023). Hijacking Endogenous Iron and GSH Via a Polyvalent Ferroptosis Agonist to Enhance Tumor Immunotherapy. Advanced Functional Materials. 33(44). 20 indexed citations

11.

Wu, Fengling, Ningjing Lei, Shenyu Yang, et al.. (2023). Treatment strategies for intrauterine adhesion: focus on the exosomes and hydrogels. Frontiers in Bioengineering and Biotechnology. 11. 1264006–1264006. 25 indexed citations

12.

Zhou, Junying, Ningjing Lei, Ruixia Guo, et al.. (2023). Hypoxic tumor cell-derived small extracellular vesicle miR-152-3p promotes cervical cancer radioresistance through KLF15 protein. Radiation Oncology. 18(1). 183–183. 9 indexed citations

13.

Chang, Lei, Ningjing Lei, Junying Zhou, et al.. (2023). Characterization of fecal microbiota in cervical cancer patients associated with tumor stage and prognosis. Frontiers in Cellular and Infection Microbiology. 13. 1145950–1145950. 16 indexed citations

14.

Cao, Hong, Ni Chen, Ruoqi Wang, et al.. (2022). Claudin-12 Deficiency Inhibits Tumor Growth by Impairing Transendothelial Migration of Myeloid-Derived Suppressor Cells. Cancer Research. 82(13). 2472–2484. 7 indexed citations

15.

Zhou, Junying, Ningjing Lei, Ruixia Guo, et al.. (2022). Recent progress of the tumor microenvironmental metabolism in cervical cancer radioresistance. Frontiers in Oncology. 12. 999643–999643. 13 indexed citations

16.

Wang, Yuan, Haiyang Liu, Yangyang Bian, et al.. (2020). Low SCRIB expression in fibroblasts promotes invasion of lung cancer cells. Life Sciences. 256. 117955–117955. 9 indexed citations

17.

Peng, Bo, Ningjing Lei, Yurong Chai, Edward K. L. Chan, & Jian-Ying Zhang. (2014). CIP2A regulates cancer metabolism and CREB phosphorylation in non-small cell lung cancer. Molecular BioSystems. 11(1). 105–114. 14 indexed citations

18.

Liu, Xinxin, Bo Peng, Yang Li, et al.. (2014). p90/CIP2A mediates breast cancer cell proliferation and apoptosis. Molecular Biology Reports. 41(11). 7471–7478. 8 indexed citations

19.

Ren, Pengfei, Hua Ye, Liping Dai, et al.. (2013). Peroxiredoxin 1 is a tumor-associated antigen in esophageal squamous cell carcinoma. Oncology Reports. 30(5). 2297–2303. 43 indexed citations

20.

Shao, Qing, Pengfei Ren, Yang Li, et al.. (2012). Autoantibodies against glucose-regulated protein 78 as serological diagnostic biomarkers in hepatocellular carcinoma. International Journal of Oncology. 41(3). 1061–1067. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact